Non-Viral Vectors In Gene Therapy: LNPs In The Spotlight
Source: Single Use Support
Gene therapy has emerged as a promising approach for treating genetic diseases by introducing therapeutic nucleic acids into target cells. The vectors used to deliver therapeutic genes like mRNA and other nucleic acids into target cells are central to the success of these gene therapy. While viral vectors have traditionally dominated the field, non-viral vectors have emerged as an alternative with significant advantages.
Learn about the types of non-viral vectors, the advantages of lipid-based nanoparticles (LNPs), the applications of LNP, the challenges with non-viral vectors in gene therapy, and more.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Single Use Support
This website uses cookies to ensure you get the best experience on our website. Learn more